|
|
Elution of a Small Molecule from a Bio Ceramic Collagen Bone Graft Device Heals Bone while InhibitingBreast Cancer Bone Metastases |
| 2 R44 CA221553-02A1 |
|
NCI |
2021 |
|
|
Project 1: Developing Immune Checkpoint Controlled Release Biomaterials for Caner Immunotherapy |
| 2 U54 CA163066-11 |
|
NCI |
2021 |
|
|
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education
[Parent Title: 2/2 Langston University-UNTHSC Partnership for Cancer Research and Education] |
| 5 P20 CA233355-04 |
|
NCI |
2021 |
|
|
Career Enhancement Program
[Parent Title: SPORE in Cervical Cancer] |
| 5 P50 CA098252-18 |
|
NCI |
2021 |
|
|
Career Enhancement Program |
| 5 P50 CA228991-04 |
|
NCI |
2021 |
|
|
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors |
| 5 R01 CA166379-09 |
|
NCI |
2021 |
|
|
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy |
| 5 R01 CA221197-04 |
KAHALLEY, LISA SCHUM |
NCI |
2021 |
|
|
Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer |
| 5 R01 CA222605-04 |
|
NCI |
2021 |
|
|
Ameliorating lymphocyte depletion and functional impairment following lung SBRT |
| 5 R01 CA234281-03 |
|
NCI |
2021 |
|
|
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to Phase III Study |
| 5 R01 CA235726-03 |
|
NCI |
2021 |
